BioCentury
ARTICLE | Politics & Policy

FDA, states to discuss compounding oversight

December 1, 2012 2:33 AM UTC

FDA said it will hold an intergovernmental meeting in December with representatives from all 50 states to discuss the role of FDA and states in the oversight of compounding pharmacies. The agency said the focus should be on clearly defining traditional compounding that should be overseen by the states and higher risk non-traditional pharmacy compounding that would require federal compliance. The agency subsequently will hold a public meeting on Dec. 19 to discuss the results of the intergovernmental meeting. ...